"10.1371_journal.pone.0120030","plos one","2015-03-19T00:00:00Z","Sanne C T Peeters; Vincent van de Ven; Ed H B M Gronenschild; Ameera X Patel; Petra Habets; Rainer Goebel; Jim van Os; Machteld Marcelis; Genetic Risk and Outcome of Psychosis (G.R.O.U.P.)","Dept. of Psychiatry and Psychology, School for Mental Health and Neuroscience, EURON, Maastricht University Medical Center, Maastricht, The Netherlands; Dept. of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, University of Maastricht, Maastricht, The Netherlands; Behavioral and Clinical Neuroscience Institute, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Kings College London, Kings Health Partners, Department of Psychosis Studies Institute of Psychiatry, London, United Kingdom; Institute for Mental Health Care Eindhoven (GGzE), Eindhoven, The Netherlands","Conceived and designed the experiments: MM JvO RG. Performed the experiments: PH. Analyzed the data: SP EHBMG VvdV AXP MM. Contributed reagents/materials/analysis tools: EHBMG VvdV AXP. Wrote the paper: SP MM.","The authors of this manuscript have read the journals policy and have the following competing interests: Jim van Os is or has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from, Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GlaxoSmithKline, AstraZeneca, Pfizer and Servier. Machteld Marcelis has received financial compensation as an independent symposium speaker from Eli Lilly and Janssen-Cilag. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials. All other authors report no biomedical financial interests or potential conflicts of interest.","2015","03","Sanne C T Peeters","SCTP",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
